Proteomics

Dataset Information

0

Proteomic Analysis of Urinary Extracellular Vesicles


ABSTRACT: Novel therapies in autosomal dominant polycystic kidney disease (ADPKD) signal the need for markers of disease progression or response to therapy. This study aimed to identify disease-associated proteins in urinary extracellular vesicles (uEVs), which include exosomes, in patients with ADPKD. We performed quantitative proteomics on uEVs using a labeled approach (healthy vs. ADPKD) and then using a label-free approach in different subjects (healthy vs. ADPKD vs. non-ADPKD chronic kidney disease [CKD]). In both experiments, thirty proteins were consistently more abundant (≥ 2-fold) in ADPKD-uEVs compared with healthy and CKD uEVs. Of these proteins, periplakin, envoplakin, villin-1, complement C3 and C9 were selected for confirmation, because (1) they were also significantly overrepresented in pathway analysis, and (2) they have been previously implicated in the pathogenesis of ADPKD. Immunoblotting was used to validate the proteomics results, confirming higher abundances of the selected proteins in ADPKD-uEVs in three independent groups of ADPKD-patients. While villin-1, periplakin and envoplakin were more abundant in advanced stages of the disease, complement was already higher in uEVs of young ADPKD patients with preserved renal function. Furthermore, all five proteins correlated positively with height adjusted total kidney volume. The proteins of interest were also analyzed in kidney tissues from kidney-specific-tamoxifen-inducible Pkd1-deletion mice, demonstrating higher expression in more severe stages of the disease. In summary, proteomic analysis of uEVs identified plakins and complement as disease-associated proteins in ADPKD. These proteins are new candidates for evaluation as biomarkers or targets for therapy in ADPKD.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Urine

DISEASE(S): Polycystic Kidney

SUBMITTER: Jeroen Demmers  

LAB HEAD: Jeroen Demmers

PROVIDER: PXD003298 | Pride | 2016-03-15

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
1374_27sept13_1en2_DM_hilic_01.RAW Raw
1374_27sept13_1en2_DM_hilic_02.RAW Raw
1374_27sept13_1en2_DM_hilic_03.RAW Raw
1374_27sept13_1en2_DM_hilic_04.RAW Raw
1374_27sept13_1en2_DM_hilic_05.RAW Raw
Items per page:
1 - 5 of 60
altmetric image

Publications

Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease.

Salih Mahdi M   Demmers Jeroen A JA   Bezstarosti Karel K   Leonhard Wouter N WN   Losekoot Monique M   van Kooten Cees C   Gansevoort Ron T RT   Peters Dorien J M DJ   Zietse Robert R   Hoorn Ewout J EJ  

Journal of the American Society of Nephrology : JASN 20160303 10


Novel therapies in autosomal dominant polycystic kidney disease (ADPKD) signal the need for markers of disease progression or response to therapy. This study aimed to identify disease-associated proteins in urinary extracellular vesicles (uEVs), which include exosomes, in patients with ADPKD. We performed quantitative proteomics on uEVs from healthy controls and patients with ADPKD using a labeled approach and then used a label-free approach with uEVs of different subjects (healthy controls vers  ...[more]

Similar Datasets

2016-10-21 | MSV000080264 | MassIVE
2023-12-18 | PXD042533 | Pride
2020-06-01 | PXD017213 | Pride
2012-02-16 | E-GEOD-35831 | biostudies-arrayexpress
2019-12-24 | E-MTAB-8086 | biostudies-arrayexpress
2019-06-13 | PXD012582 | Pride
2008-12-28 | E-GEOD-13452 | biostudies-arrayexpress
2019-12-01 | GSE110057 | GEO
2017-07-05 | E-MTAB-4188 | biostudies-arrayexpress
2017-07-05 | E-MTAB-4189 | biostudies-arrayexpress